GlaxoSmithKline Pharmaceuticals Overview

  • Status
  • Public
  • Employees
  • 4,364
  • Stock Symbol
  • 500660
Stock Symbol
  • Investments
  • 2
  • Share Price
  • $20.40
  • (As of Monday Closing)

GlaxoSmithKline Pharmaceuticals General Information


GlaxoSmithKline Pharmaceuticals Ltd is an India-based subsidiary of GlaxoSmithKline plc. GSK India develops and manufactures medicines, vaccines, and consumer products. Its medicines portfolio includes prescription drugs for conditions that include asthma, infectious diseases, mental health, and digestion, as well as nonprescription nutrition and cosmetic products. Its vaccines product line includes treatments for conditions such as influenza, HPV, hepatitis, and measles. Its consumer healthcare products include Horlicks-brand packaged food and beverage powders among other retail products. The company derives most of its revenue from India.

Contact Information

Ownership Status
Publicly Held
Financing Status
Primary Industry
Stock Exchange
Primary Office
  • Mumbai
  • India
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

GlaxoSmithKline Pharmaceuticals Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$20.40 $20.81 $13.88 - $24.51 $3.46B 169M 3.29K -$0.27

GlaxoSmithKline Pharmaceuticals Financials Summary

In Thousands,
TTM 30-Sep-2020 FY 2020 31-Mar-2020 FY 2019 31-Mar-2019 FY 2018 31-Mar-2018
EV 3,598,766 2,665,745 2,972,013 2,698,465
Revenue 418,266 453,815 446,922 445,384
EBITDA (18,140) 44,836 93,515 81,516
Net Income (45,566) 13,118 63,634 54,400
Total Assets 369,576 415,744 563,190 606,333
Total Debt 5,937 5,548 84 152
Public Fundamental Data provided by Morningstar, Inc. disclaimer

GlaxoSmithKline Pharmaceuticals Board Members (2)

Name Representing Role Since
0. 00000000 Self Board Member 000 0000
00000 000000000 Self Independent and Non-Executive Director 000 0000
To view GlaxoSmithKline Pharmaceuticals’s complete board members history, request access »

GlaxoSmithKline Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GlaxoSmithKline Pharmaceuticals Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000 16-Jul-2015 00000 00000 00 00000 Biotechnology
Silarus Therapeutics 22-Sep-2014 Early Stage VC 0000 Drug Discovery
To view GlaxoSmithKline Pharmaceuticals’s complete investments history, request access »